About Werfen
Powering Patient Care
In everything we do, we use our passion and long-term vision to develop meaningful innovations that truly enhance patient care and help create healthier societies worldwide.
Omixon is now part of Werfen.
On October 16, 2024, Werfen completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics.
Our focus on Specialized Diagnostics:
Hemostasis
Our Hemostasis product line is comprised of in vitro diagnostic systems, reagents, information management and service, used to diagnose and guide treatment of thrombotic and bleeding disorders. Ultimately, our solutions improve the quality of patient care, lower costs, and assure regulatory compliance in the clinical laboratory.
Acute Care Diagnostics
Integrated and comprehensive whole blood testing product line helps clinicians and laboratorians achieve better outcomes, lower costs, assure regulatory compliance and save time in hospital acute care settings. From cardiovascular operating rooms and catheterization labs, to intensive care units and emergency departments, our Acute Care Diagnostic solutions address today's healthcare challenges by improving efficiency and enhancing patient care.
Transfusion
Offering the broadest range of manual and automated solutions, our Transfusion portfolio delivers results accurately, efficiently and productively. A comprehensive line of serology reagents, fully automated instrumentation, industry-leading data management software and molecular products, help ensure donor-recipient compatibility for those in need of a lifesaving blood transfusion.
Autoimmunity
Through a dedicated focus on autoimmune in vitro diagnostics and lab automation, we anticipate the needs of the world's most advanced laboratories and clinics. Our highly accurate reagents and automated systems are designed to serve labs of all sizes, and they help improve the way patients with autoimmune diseases are diagnosed, monitored, and treated around the world.
Transplant
Featuring molecular and antibody-based assays and software for specialized HLA testing, our Transplant products are used to determine pretransplant compatibility between donors and recipients, and for post-transplant monitoring. By providing high-quality assays, accurate test results, and innovative tools, we can help change the practice of transplant medicine.
Other Areas of Expertise:
Immunoassay
Clinical Chemistry
Complete solutions for the chemistry and pharma-toxicology lab community
MORE INFORMATIONClinical Chemistry
"We are fortunate to have best-in-class products and the resources needed to succeed. We are focused on capturing the full value of our portfolio to power patient care and are committed to representing our Values in all that we do."
Bill Crandell
Vice President Commercial Operations, North America.
CAREERS
Make an impact with Werfen
We recognize that each employee is essential to our success. That’s why we’ve built an environment that nurtures, supports and rewards the unique contributions of every individual.
What's happening
News
Something new is always happening in our world, keep up to date with news
December 3, 2024
July 15, 2024 - Barcelona, Spain
